Notis Mc Conarty Edward Bristol Myers Squibb CO Transaction History

Notis Mc Conarty Edward

  • $217 Million
  • Q3 2024

A detailed history of Notis Mc Conarty Edward transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Notis Mc Conarty Edward holds 6,235 shares of BMY stock, worth $360,133. This represents 0.15% of its overall portfolio holdings.

Number of Shares
6,235
Previous 9,335 33.21%
Holding current value
$360,133
Previous $387,000 16.8%
% of portfolio
0.15%
Previous 0.15%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$39.66 - $51.75 $122,945 - $160,425
-3,100 Reduced 33.21%
6,235 $322,000
Q2 2024

Aug 12, 2024
SELL
$40.25 - $52.99 $32,200 - $42,392
-800 Reduced 7.89%
9,335 $387,000
Q1 2024

Apr 29, 2024
SELL
$47.98 - $54.4 $161,932 - $183,600
-3,375 Reduced 24.98%
10,135 $549,000
Q4 2023

Feb 13, 2024
SELL
$48.48 - $57.85 $335,239 - $400,032
-6,915 Reduced 33.86%
13,510 $693,000
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $63,679 - $71,203
-1,100 Reduced 5.11%
20,425 $1.19 Million
Q4 2022

Feb 09, 2023
SELL
$68.48 - $81.09 $54,784 - $64,872
-800 Reduced 3.58%
21,525 $1.55 Million
Q3 2022

Nov 08, 2022
SELL
$0.13 - $76.84 $9 - $5,763
-75 Reduced 0.33%
22,325 $1.59 Million
Q3 2021

Nov 10, 2021
BUY
$59.17 - $69.31 $32,543 - $38,120
550 Added 2.52%
22,400 $1.33 Million
Q1 2021

May 17, 2021
BUY
$59.34 - $66.74 $44,505 - $50,054
750 Added 3.55%
21,850 $1.38 Million
Q4 2020

Feb 16, 2021
SELL
$57.74 - $65.43 $43,305 - $49,072
-750 Reduced 3.43%
21,100 $1.31 Million
Q3 2020

Oct 28, 2020
SELL
$57.43 - $63.64 $57,142 - $63,321
-995 Reduced 4.36%
21,850 $1.32 Million
Q2 2020

Jul 28, 2020
SELL
$54.82 - $64.09 $50,434 - $58,962
-920 Reduced 3.87%
22,845 $1.34 Million
Q1 2020

May 07, 2020
SELL
$46.4 - $67.43 $4,640 - $6,743
-100 Reduced 0.42%
23,765 $1.33 Million
Q4 2019

Jan 15, 2020
BUY
$49.21 - $64.19 $180,600 - $235,577
3,670 Added 18.17%
23,865 $1.53 Million
Q3 2019

Nov 04, 2019
SELL
$42.77 - $50.71 $7,099 - $8,417
-166 Reduced 0.82%
20,195 $1.02 Million
Q2 2019

Jul 24, 2019
SELL
$44.62 - $49.34 $23,425 - $25,903
-525 Reduced 2.51%
20,361 $924,000
Q1 2019

Apr 29, 2019
SELL
$45.12 - $53.8 $27,072 - $32,280
-600 Reduced 2.79%
20,886 $997,000
Q4 2018

Jan 24, 2019
SELL
$48.76 - $63.23 $1,219 - $1,580
-25 Reduced 0.12%
21,486 $1.12 Million
Q1 2018

Apr 24, 2018
SELL
$59.92 - $68.98 $11,984 - $13,796
-200 Reduced 0.92%
21,511 $1.36 Million
Q4 2017

Feb 02, 2018
BUY
$59.94 - $65.35 $392,607 - $428,042
6,550 Added 43.2%
21,711 $1.33 Million
Q3 2017

Oct 26, 2017
BUY
$55.23 - $63.74 $837,342 - $966,362
15,161
15,161 $966,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Notis Mc Conarty Edward Portfolio

Follow Notis Mc Conarty Edward and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Notis Mc Conarty Edward, based on Form 13F filings with the SEC.

News

Stay updated on Notis Mc Conarty Edward with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email